Elexacaftor/tezacaftor/ivacaftor's effects on cystic fibrosis infections are maintained, but not increased, after 3.5 years of treatment.
作者信息
Morgan Sarah J, Coulter Ellis, Betts Hannah L, Solomon George M, Clancy John P, Rowe Steven M, Nichols David P, Singh Pradeep K
机构信息
University of Washington, Seattle, Washington, USA.
University of Alabama, Birmingham, Alabama, USA.
出版信息
J Clin Invest. 2024 Sep 5;134(20):e184171. doi: 10.1172/JCI184171.
Abstract
摘要
Zotero 插件